Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis.

Moledina DG, Wilson FP, Pober JS, Perazella MA, Singh N, Luciano RL, Obeid W, Lin H, Kuperman M, Moeckel GW, Kashgarian M, Cantley LG, Parikh CR.

JCI Insight. 2019 May 16;4(10). pii: 127456. doi: 10.1172/jci.insight.127456. eCollection 2019 May 16.

2.

Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis.

Wilson PC, Kashgarian M, Moeckel G.

Clin Kidney J. 2018 Apr;11(2):207-218. doi: 10.1093/ckj/sfx093. Epub 2017 Aug 31.

3.

Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction.

Ghosh M, Thangada S, Dasgupta O, Khanna KM, Yamase HT, Kashgarian M, Hla T, Shapiro LH, Ferrer FA.

PLoS One. 2018 Mar 8;13(3):e0194053. doi: 10.1371/journal.pone.0194053. eCollection 2018.

4.

Lupus and proliferative nephritis are PAD4 independent in murine models.

Gordon RA, Herter JM, Rosetti F, Campbell AM, Nishi H, Kashgarian M, Bastacky SI, Marinov A, Nickerson KM, Mayadas TN, Shlomchik MJ.

JCI Insight. 2017 May 18;2(10). pii: 92926. doi: 10.1172/jci.insight.92926. eCollection 2017 May 18.

5.

Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus.

Choi JY, Seth A, Kashgarian M, Terrillon S, Fung E, Huang L, Wang LC, Craft J.

J Immunol. 2017 Apr 1;198(7):2578-2588. doi: 10.4049/jimmunol.1601687. Epub 2017 Feb 20.

6.

Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.

Merola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S.

Transplant Proc. 2016 Nov;48(9):3106-3108. doi: 10.1016/j.transproceed.2016.04.005.

PMID:
27932157
7.

A 65-Year-Old Female from Connecticut with Orf Infection.

Estela Cubells JR, Braverman I, Kashgarian M, Lazova R.

Dermatopathology (Basel). 2016 Jun 22;3(2):55-60. doi: 10.1159/000447125. eCollection 2016 Apr-Jun.

8.

B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus.

Giles JR, Kashgarian M, Koni PA, Shlomchik MJ.

J Immunol. 2015 Sep 15;195(6):2571-9. doi: 10.4049/jimmunol.1500792. Epub 2015 Aug 12.

9.

Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+ NIK+ signalosome on Rab5+ endosomes.

Jane-wit D, Surovtseva YV, Qin L, Li G, Liu R, Clark P, Manes TD, Wang C, Kashgarian M, Kirkiles-Smith NC, Tellides G, Pober JS.

Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9686-91. doi: 10.1073/pnas.1503535112. Epub 2015 Jul 20.

10.

Akt Substrate of 160 kD Regulates Na+,K+-ATPase Trafficking in Response to Energy Depletion and Renal Ischemia.

Alves DS, Thulin G, Loffing J, Kashgarian M, Caplan MJ.

J Am Soc Nephrol. 2015 Nov;26(11):2765-76. doi: 10.1681/ASN.2013101040. Epub 2015 Mar 18.

11.

Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.

Teichmann LL, Cullen JL, Kashgarian M, Dong C, Craft J, Shlomchik MJ.

Immunity. 2015 Mar 17;42(3):552-65. doi: 10.1016/j.immuni.2015.02.015.

12.

Semaphorin3a promotes advanced diabetic nephropathy.

Aggarwal PK, Veron D, Thomas DB, Siegel D, Moeckel G, Kashgarian M, Tufro A.

Diabetes. 2015 May;64(5):1743-59. doi: 10.2337/db14-0719. Epub 2014 Dec 4.

13.

14C Analysis of protein extracts from Bacillus spores.

Cappuccio JA, Falso MJ, Kashgarian M, Buchholz BA.

Forensic Sci Int. 2014 Jul;240:54-60. doi: 10.1016/j.forsciint.2014.04.003. Epub 2014 Apr 13.

14.

Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.

Veron D, Aggarwal PK, Velazquez H, Kashgarian M, Moeckel G, Tufro A.

J Am Soc Nephrol. 2014 Aug;25(8):1814-24. doi: 10.1681/ASN.2013070752. Epub 2014 Feb 27.

15.

Mutation of POLB causes lupus in mice.

Senejani AG, Liu Y, Kidane D, Maher SE, Zeiss CJ, Park HJ, Kashgarian M, McNiff JM, Zelterman D, Bothwell AL, Sweasy JB.

Cell Rep. 2014 Jan 16;6(1):1-8. doi: 10.1016/j.celrep.2013.12.017. Epub 2014 Jan 2.

16.

Ultrafast shock initiation of exothermic chemistry in hydrogen peroxide.

Armstrong MR, Zaug JM, Goldman N, Kuo IF, Crowhurst JC, Howard WM, Carter JA, Kashgarian M, Chesser JM, Barbee TW, Bastea S.

J Phys Chem A. 2013 Dec 12;117(49):13051-8. doi: 10.1021/jp407595u. Epub 2013 Oct 25.

PMID:
24102452
17.

Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus.

Teichmann LL, Schenten D, Medzhitov R, Kashgarian M, Shlomchik MJ.

Immunity. 2013 Mar 21;38(3):528-40. doi: 10.1016/j.immuni.2012.11.017. Epub 2013 Mar 14.

18.

Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1.

Nickerson KM, Cullen JL, Kashgarian M, Shlomchik MJ.

J Immunol. 2013 Apr 15;190(8):3889-94. doi: 10.4049/jimmunol.1203525. Epub 2013 Mar 6.

19.

Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.

Look M, Stern E, Wang QA, DiPlacido LD, Kashgarian M, Craft J, Fahmy TM.

J Clin Invest. 2013 Apr;123(4):1741-9.

20.

NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.

Campbell AM, Kashgarian M, Shlomchik MJ.

Sci Transl Med. 2012 Oct 24;4(157):157ra141. doi: 10.1126/scitranslmed.3004801.

21.

Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.

Veron D, Villegas G, Aggarwal PK, Bertuccio C, Jimenez J, Velazquez H, Reidy K, Abrahamson DR, Moeckel G, Kashgarian M, Tufro A.

PLoS One. 2012;7(7):e40589. doi: 10.1371/journal.pone.0040589. Epub 2012 Jul 13.

22.

An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred.

Yang CS, Lu Y, Farhi A, Nelson-Williams C, Kashgarian M, Glusac EJ, Lifton RP, Antaya RJ, Choate KA.

Pediatr Dermatol. 2012 Nov-Dec;29(6):725-31. doi: 10.1111/j.1525-1470.2012.01757.x. Epub 2012 Apr 20.

23.

Increased tubular proliferation as an adaptive response to glomerular albuminuria.

Guo JK, Marlier A, Shi H, Shan A, Ardito TA, Du ZP, Kashgarian M, Krause DS, Biemesderfer D, Cantley LG.

J Am Soc Nephrol. 2012 Mar;23(3):429-37. doi: 10.1681/ASN.2011040396. Epub 2011 Dec 22.

24.
25.

B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice.

Teichmann LL, Kashgarian M, Weaver CT, Roers A, Müller W, Shlomchik MJ.

J Immunol. 2012 Jan 15;188(2):678-85. doi: 10.4049/jimmunol.1102456. Epub 2011 Dec 9.

26.

Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia.

Seo-Mayer PW, Thulin G, Zhang L, Alves DS, Ardito T, Kashgarian M, Caplan MJ.

Am J Physiol Renal Physiol. 2011 Dec;301(6):F1346-57. doi: 10.1152/ajprenal.00420.2010. Epub 2011 Aug 17.

27.

Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

Veron D, Bertuccio CA, Marlier A, Reidy K, Garcia AM, Jimenez J, Velazquez H, Kashgarian M, Moeckel GW, Tufro A.

Diabetologia. 2011 May;54(5):1227-41. doi: 10.1007/s00125-010-2034-z. Epub 2011 Feb 12.

28.

Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage.

Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, Shlomchik MJ.

Immunity. 2010 Dec 14;33(6):967-78. doi: 10.1016/j.immuni.2010.11.025.

29.

A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.

Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R.

J Immunol. 2011 Jan 1;186(1):527-38. doi: 10.4049/jimmunol.1001767. Epub 2010 Nov 24.

30.

The maximal cytoprotective function of the heat shock protein 27 is dependent on heat shock protein 70.

Sreedharan R, Riordan M, Thullin G, Van Why S, Siegel NJ, Kashgarian M.

Biochim Biophys Acta. 2011 Jan;1813(1):129-35. doi: 10.1016/j.bbamcr.2010.08.012. Epub 2010 Oct 8.

31.

Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome.

Veron D, Reidy K, Marlier A, Bertuccio C, Villegas G, Jimenez J, Kashgarian M, Tufro A.

Am J Pathol. 2010 Nov;177(5):2225-33. doi: 10.2353/ajpath.2010.091146. Epub 2010 Sep 9.

32.

Altered renal proximal tubular endocytosis and histology in mice lacking myosin-VI.

Gotoh N, Yan Q, Du Z, Biemesderfer D, Kashgarian M, Mooseker MS, Wang T.

Cytoskeleton (Hoboken). 2010 Mar;67(3):178-92. doi: 10.1002/cm.20435.

33.

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K, Shlomchik MJ.

J Immunol. 2010 Feb 15;184(4):1840-8. doi: 10.4049/jimmunol.0902592. Epub 2010 Jan 20.

34.

ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Odegard JM, DiPlacido LD, Greenwald L, Kashgarian M, Kono DH, Dong C, Flavell RA, Craft J.

J Immunol. 2009 Apr 1;182(7):4076-84. doi: 10.4049/jimmunol.0800758.

35.

Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphology.

Ishibe S, Karihaloo A, Ma H, Zhang J, Marlier A, Mitobe M, Togawa A, Schmitt R, Czyczk J, Kashgarian M, Geller DS, Thorgeirsson SS, Cantley LG.

Development. 2009 Jan;136(2):337-45. doi: 10.1242/dev.024463.

36.

Disruption of Myosin 1e promotes podocyte injury.

Krendel M, Kim SV, Willinger T, Wang T, Kashgarian M, Flavell RA, Mooseker MS.

J Am Soc Nephrol. 2009 Jan;20(1):86-94. doi: 10.1681/ASN.2007111172. Epub 2008 Nov 12.

37.

A case of an acute kidney injury secondary to an implanted aminoglycoside.

Wu IM, Marin EP, Kashgarian M, Brewster UC.

Kidney Int. 2009 May;75(10):1109-12. doi: 10.1038/ki.2008.386. Epub 2008 Jul 30. No abstract available.

38.

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.

Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP.

J Clin Endocrinol Metab. 2008 Aug;93(8):3117-23. doi: 10.1210/jc.2008-0594. Epub 2008 May 27.

39.

Circumscribed palmar hypokeratosis: two cases and a review of the literature.

Barry CI, Glusac EJ, Kashgarian M, Gwin K, McNiff JM.

J Cutan Pathol. 2008 May;35(5):484-7. doi: 10.1111/j.1600-0560.2007.00835.x.

PMID:
18399810
40.

Depletion of B cells in murine lupus: efficacy and resistance.

Ahuja A, Shupe J, Dunn R, Kashgarian M, Kehry MR, Shlomchik MJ.

J Immunol. 2007 Sep 1;179(5):3351-61.

41.

The commonly used beta-actin-GFP transgenic mouse strain develops a distinct type of glomerulosclerosis.

Guo JK, Cheng EC, Wang L, Swenson ES, Ardito TA, Kashgarian M, Cantley LG, Krause DS.

Transgenic Res. 2007 Dec;16(6):829-34. Epub 2007 Jun 27.

PMID:
17594530
42.

PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.

Zhang JJ, Kelm RJ, Biswas P, Kashgarian M, Madri JA.

J Cell Physiol. 2007 Feb;210(2):527-37.

PMID:
17111362
43.

The contribution of quantitative techniques including morphometry to renal diagnosis.

Kashgarian M.

Ultrastruct Pathol. 2006 Sep-Oct;30(5):339-43.

PMID:
17090513
44.

Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog.

Choi JY, Gao W, Odegard J, Shiah HS, Kashgarian M, McNiff JM, Baker DC, Cheng YC, Craft J.

Arthritis Rheum. 2006 Oct;54(10):3277-83.

45.

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ.

Immunity. 2006 Sep;25(3):417-28.

46.

Modulation of renal cell injury by heat shock proteins: lessons learned from the immature kidney.

Riordan M, Sreedharan R, Kashgarian M, Siegel NJ.

Nat Clin Pract Nephrol. 2006 Mar;2(3):149-56. Review.

PMID:
16932413
47.

Prevention of mesangial sclerosis by bone marrow transplantation.

Guo JK, Ardito TA, Kashgarian M, Krause DS.

Kidney Int. 2006 Sep;70(5):910-3. Epub 2006 Jul 19.

48.

Differential expression of matrix metalloproteinases and their inhibitors in human and mouse lung development.

Ryu J, Vicencio AG, Yeager ME, Kashgarian M, Haddad GG, Eickelberg O.

Thromb Haemost. 2005 Jul;94(1):175-83.

PMID:
16113801
49.

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.

Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ.

J Exp Med. 2005 Jul 18;202(2):321-31.

50.

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF.

J Am Soc Nephrol. 2005 May;16(5):1392-403. Epub 2005 Mar 30. Review.

Supplemental Content

Loading ...
Support Center